Synthesis and evaluation of analogues of congo red as potential compounds against transmissible spongiform encephalopathies

European Journal of Medicinal Chemistry

Volumn 38, Issue 6, 2003, Pages 567-579

  Rudyk, Hélène ^a   Knaggs, Michael H ^a   Vasiljevic, Snezana ^b   Hope, James ^b   Birkett, Chris ^b   Gilbert, Ian H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Azo dyes; Prions; TSE

Indexed keywords

3,3' DICHLOROBENZIDINE; 4 AMINO 3 (2 PHENYL 1 DIAZENYL) 1 BENZENESULFONIC ACID; 4 AMINO 3 (2 PHENYL 1 DIAZENYL) 1 BENZOIC ACID; 4 AMINO 3 (2 PHENYL 1 DIAZENYL) 1 NAPHTHALENESULFONIC ACID; 4,4' BIS(2,2,2 TRIFLUOROACETYL)AMINO 3,3' (BIPHENYL 4,4' DIYLBISAZO)BISNAPHTHALENE 1 SULFONIC ACID; 4,4' DIAMINO 3,3' (3,3' DIMETHOXYBIPHENYL 4,4' DIYLBISAZO)BISNAPHTHALENE 1 SULFONIC ACID; 4,4' DIHYDROXY 3,3' (3,3' DIMETHOXYBIPHENYL 4,4' DIYLBISAZO)BISNAPHTHALENE 1 SULFONIC ACID; 4,4' DIHYDROXY 3,3' (3,3' DIMETHOXYBIPHENYL 4,4' DIYLBISAZO)BISNAPHTHALENE 6 AMINO 2 SULFONIC ACID; 4,4' DIHYDROXY 3,3' (BIPHENYL 4,4' DIYLBISAZO)BISNAPHTHALENE 1 SULFONIC ACID; 6,6' DIHYDROXY 3,3' (3,3' DIMETHOXYBIPHENYL 4,4' DIYLBISAZO)DIBENZOIC ACID; 6,6' DIHYDROXY 3,3' (3,3' SULFONYLBISBIPHENYLAZO)DIBENZOIC ACID; 6,6' DIHYDROXY 3,3' (4,4' SULFONYLBISBIPHENYLAZO)DIBENZOIC ACID; 6,6' DIHYDROXY 3,3' BIPHENYL 4,4' DIYLBISAZODIBENZOIC ACID; ANILINE DERIVATIVE; AROMATIC COMPOUND; AZO DYE; BENZIDINE; BENZIDINE DERIVATIVE; BIS [3 (1 AMINO 4 SULFO 2 NAPHTHYLAZO)PHENYL]SULFONE; BIS [4 (1 AMINO 4 SULFO 2 NAPHTHYLAZO)PHENYL]SULFONE; BIS [4 (1 AMINO 4 SULFO 2 PHENYLAZO)PHENYL]SULFONE; CARBOXYLIC ACID DERIVATIVE; CONGO RED; DAPSONE; DIAMINE DERIVATIVE; DIAZONIUM COMPOUND; SULFONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; MOLECULAR MODEL; NONHUMAN; PRION DISEASE; SCRAPIE; SHEEP; SHEEP DISEASE; STRUCTURE ACTIVITY RELATION;

EID: 0038798675     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00081-3     Document Type: Article

References (43)

1. Gilbert I.H., Rudyk H. Int. Antiviral News. 7:1999;78-81.
2. Prusiner S.B., Scott M.R., DeArmond S.J., Cohen F.E. Cell. 93:1998;337-348.
3. Leimann S., Glockshuber R. Biochem. Biophys. Res. Commun. 250:1998;187-193.
4. Wells G.A.H., Scott A.C., Johnson C.T., Gunning R.F., Hancock R.D., Jeffrey M., Dawson M., Bradley R. Vet. Rec. 121:1987;419-420.
5. Brown D.R., Besinger A. J. Biochem. 334:1998;423-429.
6. Nishida N. Cell. Mol. Neurobiol. 17:1997;537-545.
7. Tobler I., Gaus S.E., Deboer T., Achermann P., Fischer M., Rulicke T., Moser M., Oesch B., McBride P.A., Manson J.C. Nature. 380:1996;639-642.
8. Herms J.W., Madlung A., Brown D.R., Kretzschmar H.A. Glia. 21:1997;253-257.
9. Basler K., Oesch B., Scott M., Westaway D., Walchli M., Groth D.F., McKinley M.P., Prusiner S.B., Weissmann C. Cell. 46:1986;417-428.
10. Caughey B.W., Dong A., Bhat K.S., Ernst D., Hayes S.F., Caughey W.S. Biochemistry. 31:1991;7672-7680.
11. Caughey B., Race R.E., Ernst D., Buchmeier M.J., Chesebro B. J. Virol. 63:1989;175-181.
12. Klunk W.E., Debnath M.L., Pettegrew J.W. Neurobiol. Aging. 15:1994;691-698.
13. Caughey B., Raymond G.J. J. Virol. 67:1993;643-650.
14. Bandiera T., Lanson J., Post C., Varasi M. Curr. Med. Chem. 4:1997;159-170.
15. Pollack S.J., Sadler I.I., Hawtin S.R., Tailor V.J., Shearman M.S. Neurosci. Lett. 197:1995;211-214.
16. Caspi S., Halimi M., Yanai A., BenSasson S., Taraboulos A., Gabizon R. J. Biol. Chem. 273:1998;3484-3489.
17. Ingrosso L., Ladogana A., Pocchiari M. J. Virol. 69:1995;506-508.
18. Gray L.E., Kavlock R.J., Ostby J., Ferrell J. Teratology. 27:1983;A46.
19. Gray L.E., Ostby J., Kavlock R., Marshall R. Fundam. Appl. Toxicol. 19:1992;411-422.
20. Gray L.E., Ostby J. Fundam. Appl. Toxicol. 20:1993;177-183.
21. Bos R.P., Koopman J.P., Theuws J.L.G., Henderson P.T. Mutat. Res. 181:1987;327.
22. Zenser T., Lakshmi V., Davis B. Drug Metab. Dispos. 26:1998;856-859.
23. Demaimay R., Harper J., Gordon J., Weaver D., Chesebro B., Caughey B. J. Neurochem. 71:1998;2534-2541.
24. Zollinger H. Color Chemistry, Synthesis, Properties and Application of Organic Dyes and Pigments. 1987;Weinheim VCH.
25. Bad. Anilin-u. Sodaf., DE 84893, Fortschr. Teerfarbenfabr. Verw. Industriezweige, DE, GE, 4, 847.
26. Szadowski J. Dyes Pigments. 14:1990;217-224.
27. Freeman H.S., Kim S.-D., Gilbert R.D., Mcgregor R. Dyes Pigments. 17:1991;83-100.
28. Rudyk H., Vasiljevic S., Birkett C.R., Hope J., Gilbert I.H. J. Gen. Virol. 81:2000;1155-1164.
29. Sah P.P.T. Recl. Trav. Chim. Pays-Bas. 69:1950;1407-1434.
30. Bayer & Co., DE 38802; Fortschr. Teerfarbenfabr. Verw. Industriezweige; DE, GE, 1, 488.
31. Holmes F.H. Trans. Faraday Soc. 54:1958;1166-1171.
32. Bayer & Co.; DE 38802; Fortschr. Teerfarbenfabr. Verw. Industriezweige; DE, GE, 1, 489, 491.
33. Arcoria A., Scarlata G. Ann. Chim. (Rome). 57:1967;1125.
34. Zollinger H. Azo and Diazo Chemistry, Aliphatic and Aromatic Compounds. 1961;Interscience Publishers, Inc. New York.
35. Saunders K.H., Allen R.L.M. Aromatic Diazo Compounds. third ed. 1985;Edward Arnold Publishers Ltd, London.
36. Mathis C.A., Mahmood K., Debnath M.L., Klunk W. J. Labelled Compd. Radiopharm. 40:1997;94-95.
37. Brass K., Wittenberger W. Ber. Deut. Chem. Gesellschaft. 68:1935;1905-1912.
38. Bayer & Co., DE 31658, Fortschr. Teerfarbenfabr. Verw. Industriezweige; DE, GE, 1, 465.
39. Dewing T., Gray W.H., Platt B.C., Stephenson D. J. Chem. Soc. 1942;239-244.
40. Skowronek M., Stopa B., Konieczny L., Rybarska J., Piekarska B., Snezler E., Bakalarski G., Roterman I. Biopolymers. 46:1998;267-281.
41. Stopa B., Konieczny L., Piekarska B., Roterman I., Rybarska J., Skowronek M. Biochimie. 79:1997;23-26.
42. Stopa B., Górny M., Konieczny L., Piekarska B., Rybarska J., Skowronek M., Roterman I. Biochimie. 80:1998;963-968.
43. Szadowski J. Dyes Pigments. 14:1990;217.